Publicacións nas que colabora con Anxo Fernández Ferreiro (11)

2024

  1. Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

    Pharmaceuticals, Vol. 17, Núm. 2

  2. The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

    Pharmaceutics, Vol. 16, Núm. 1

2020

  1. Características clínicas, manejo y resultados de los pacientes con endoftalmitis estéril asociados con la inyección intravítrea de factores de crecimiento endotelial antivascular

    Archivos de la Sociedad Española de Oftalmologia, Vol. 95, Núm. 5, pp. 211-216

  2. Pharmacological advances in the treatment of age-related macular degeneration

    Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 583-598

  3. Recent research in ocular cystinosis: Drug delivery systems, cysteamine detection methods and future perspectives

    Pharmaceutics, Vol. 12, Núm. 12, pp. 1-21

2018

  1. Preclinical characterization and clinical evaluation of tacrolimus eye drops

    European Journal of Pharmaceutical Sciences, Vol. 120, pp. 152-161

  2. Review of intraocular pharmacokinetics of anti-infectives commonly used in the treatment of infectious endophthalmitis

    Pharmaceutics, Vol. 10, Núm. 2

2017

  1. Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging

    International Journal of Pharmaceutics, Vol. 528, Núm. 1-2, pp. 714-722

  2. In Vitro Evaluation of the Ophthalmic Toxicity Profile of Chlorhexidine and Propamidine Isethionate Eye Drops

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 3, pp. 202-209

  3. Preclinical PET study of intravitreal injections

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 7, pp. 2843-2851

2015

  1. Ocular safety comparison of non-steroidal anti-inflammatory eye drops used in pseudophakic cystoid macular edema prevention

    International Journal of Pharmaceutics, Vol. 495, Núm. 2, pp. 680-691